Lurasidone (CAS 367514-87-2) Suppliers and Product Information

Lurasidone is an atypical antipsychotic drug used for the treatment of schizophrenia. It acts as an antagonist at dopamine D2 and serotonin 5-HT2A receptors, and also has activity at other serotonin receptors. Lurasidone is known for its potential to improve cognitive function and has a lower risk of weight gain compared to some other antipsychotics.

Frequently Asked Questions about Lurasidone

Q: What is the recommended dosage for Lurasidone?

A: The recommended starting dose is 40 mg/day. The effective dose range is 40-120 mg/day, with a maximum recommended dose of 80 mg/day. It should be taken with food.

Q: What are the common side effects of Lurasidone?

A: Common adverse reactions include somnolence, akathisia, nausea, Parkinson's-like symptoms, and emotional anxiety.

Q: Does Lurasidone cause weight gain?

A: Lurasidone is less likely to cause weight gain compared to some other atypical antipsychotics. It also has minimal effects on glucose and lipid levels.

Q: How does Lurasidone differ from other atypical antipsychotics?

A: Lurasidone has a unique receptor binding profile, including potent antagonism at the 5-HT7 receptor. It also has low affinity for histamine H1 and muscarinic receptors, which may contribute to its favorable side effect profile.